Cargando…

Comparison of the Ki-67 score and S-phase fraction as prognostic variables in soft-tissue sarcoma

Immunohistochemically determined Ki-67 scores and flow cytometrically determined S-phase fractions were successfully evaluated from the primary tumours of 123 patients with soft-tissue sarcoma. All patients had either limb or superficial trunk tumours. Ki-67 score correlated strongly with ploidy, S-...

Descripción completa

Detalles Bibliográficos
Autores principales:	Huuhtanen, R L, Blomqvist, C P, Wiklund, T A, Böhling, T O, Virolainen, M J, Tukiainen, E J, Tribukait, B, Andersson, L C
Formato:	Texto
Lenguaje:	English
Publicado:	Nature Publishing Group 1999
Materias:	Regular Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2362649/ https://www.ncbi.nlm.nih.gov/pubmed/10070895 http://dx.doi.org/10.1038/sj.bjc.6690151

Ejemplares similares

A high proliferation rate measured by cyclin A predicts a favourable chemotherapy response in soft tissue sarcoma patients
por: Huuhtanen, R L, et al.
Publicado: (1999)

Growth rate of lung metastases and S-phase fraction as determined by flow cytometry from the primary tumour in 25 patients with bone or soft-tissue sarcomas.
por: Blomqvist, C., et al.
Publicado: (1996)

The adhesion molecule CD44v6 is associated with a high risk for local recurrence in adult soft tissue sarcomas
por: Maula, S, et al.
Publicado: (2001)

Measurement of growth rate of lung metastases in 21 patients with bone or soft-tissue sarcoma.
por: Blomqvist, C., et al.
Publicado: (1993)

Ki-67 is strongly prognostic in synovial sarcoma: analysis based on 86 patients from the Scandinavian Sarcoma Group Register
por: Skytting, B T, et al.
Publicado: (1999)

A web-based prognostic tool for extremity and trunk wall soft tissue sarcomas and its external validation
por: Sampo, M, et al.
Publicado: (2012)

(Neo)adjuvant chemotherapy and interdigitated split-course hyperfractionated radiation in high risk soft tissue sarcoma – Results from a large single-institution series
por: Nevala, Riikka, et al.
Publicado: (2019)

Improved prognosis in soft-tissue sarcoma of extremity and trunk wall: Comparison of patients diagnosed during 1998–2001 and 2005–2010 in Finland
por: Sampo, Mika M, et al.
Publicado: (2017)

Relationship Between Ultrasound Features and Ki-67 Labeling Index of Soft Tissue Sarcoma
por: Wang, Pingping, et al.
Publicado: (2021)

Type III collagen metabolism in soft tissue sarcomas.
por: Wiklund, T. A., et al.
Publicado: (1992)

Soft Tissue Sarcoma of Lower Extremity: Functional Outcome and Quality of Life
por: Kask, Gilber, et al.
Publicado: (2021)

Interobserver Variability of Ki-67 Measurement in Breast Cancer
por: Chung, Yul Ri, et al.
Publicado: (2016)

Hypodiploidy, Ki-67 growth fraction and prognosis of surgically resected lung cancers.
por: Pujol, J. L., et al.
Publicado: (1996)

Ki-67 and CD100 immunohistochemical expression is associated with local recurrence and poor prognosis in soft tissue sarcomas, respectively
por: CAMPOS, MARCELO, et al.
Publicado: (2013)

Prognostic Value of Ki-67 Index in Patients With Endometrial Stromal Sarcoma
por: Meng, Yu, et al.
Publicado: (2022)

The lack of correlation between proliferation (Ki-67, PCNA, LI, Tpot), p53 expression and radiosensitivity for head and neck cancers
por: Björk-Eriksson, T, et al.
Publicado: (1999)

Ki-67 pulmonary immunoreactivity in silver nanoparticles toxicity: Size-rate dependent genotoxic impact
por: Ali, Sanaa A., et al.
Publicado: (2022)

Immunodetectable cyclin D (1) is associated with oestrogen receptor but not Ki67 in normal, cancerous and precancerous breast lesions
por: Shoker, B S, et al.
Publicado: (2001)

Relationship between tumour shrinkage and reduction in Ki67 expression after primary chemotherapy in human breast cancer
por: Bottini, A, et al.
Publicado: (2001)

Diagnostic and Prognostic Value Of Ki67 Proliferation Fraction in Serous Effusions
por: Schönherr, Alexandra, et al.
Publicado: (2004)

Extended resection including adjacent organs and Ki-67 labeling index are prognostic factors in patients with retroperitoneal soft tissue sarcomas
por: Morizawa, Yosuke, et al.
Publicado: (2016)

To Ki or Not to Ki: Re-Evaluating the Use and Potentials of Ki-67 for T Cell Analysis
por: Di Rosa, Francesca, et al.
Publicado: (2021)

Prognostic implications of various models for calculation of S-phase fraction in 259 patients with soft tissue sarcoma
por: Gustafson, P, et al.
Publicado: (1999)

Corrigendum: To Ki or Not to Ki: Re-Evaluating the Use and Potentials of Ki-67 for T Cell Analysis
por: Di Rosa, Francesca, et al.
Publicado: (2021)

Prognostic values of proliferating cell nuclear antigen (PCNA) and Ki-67 for radiotherapy of oesophageal squamous cell carcinomas
por: Okuno, Y, et al.
Publicado: (1999)

Prognostic Impact of Jab1, p16, p21, p62, Ki67 and Skp2 in Soft Tissue Sarcomas
por: Sorbye, Sveinung W., et al.
Publicado: (2012)

Prospective evaluation of Ki-67 system in histological grading of soft tissue sarcomas in the Japan Clinical Oncology Group Study JCOG0304
por: Tanaka, Kazuhiro, et al.
Publicado: (2016)

Proliferative activity in human breast cancer: Ki-67 automated evaluation and the influence of different Ki-67 equivalent antibodies
por: Fasanella, S, et al.
Publicado: (2011)

Ki-67 gene expression
por: Uxa, Sigrid, et al.
Publicado: (2021)

The intrinsically disorderly story of Ki-67
por: Remnant, Lucy, et al.
Publicado: (2021)

Cyclin D1 expression in transitional cell carcinoma of the bladder: correlation with p53, waf1, pRb and Ki67
por: Tut, V M, et al.
Publicado: (2001)

Independent Clinical Validation of the Automated Ki67 Scoring Guideline from the International Ki67 in Breast Cancer Working Group
por: Boyaci, Ceren, et al.
Publicado: (2021)

Low correlation between Ki67 assessed by qRT-PCR in Oncotype Dx score and Ki67 assessed by Immunohistochemistry
por: Selmani, Zohair, et al.
Publicado: (2022)

Ki 67 is a major, but not the sole determinant of Oncotype Dx recurrence score
por: Sahebjam, S, et al.
Publicado: (2011)

Body weight and risk of soft-tissue sarcoma
por: Tavani, A, et al.
Publicado: (1999)

Human papillomavirus, p16(INK4A), and Ki-67 in relation to clinicopathological variables and survival in primary carcinoma of the vagina
por: Hellman, K, et al.
Publicado: (2014)

Prognostic impact of CD57, CD68, M-CSF, CSF-1R, Ki67 and TGF-beta in soft tissue sarcomas
por: Sorbye, Sveinung W, et al.
Publicado: (2012)

Functional Outcome Measurement in Patients with Lower-Extremity Soft Tissue Sarcoma: A Systematic Literature Review
por: Kask, Gilber, et al.
Publicado: (2019)

Assessment of Ki67 in Breast Cancer: Updated Recommendations From the International Ki67 in Breast Cancer Working Group
por: Nielsen, Torsten O, et al.
Publicado: (2020)

Evaluation of the proliferation marker Ki-67 in gliomas: Interobserver variability and digital quantification
por: Nielsen, Ljudmilla A. G., et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_sdkcuean4hqrt7arqmhijno33n